ロード中...
A pharmacogenetic study of vorinostat glucuronidation
High interindividual pharmacokinetic variability was observed in phase 1 studies of vorinostat (suberoylanilide hydroxamic acid), an oral histone deacetylase inhibitor. Thus, we hypothesized that the variability can be explained by genetic variants of the uridine 5′-diphosphate-glucuronosyltransfera...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3636562/ https://ncbi.nlm.nih.gov/pubmed/20729791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0b013e32833e1b37 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|